200086686
Novus Biologicals™ Proprotein Convertase 9/PCSK9 Antibody (tafolecimab) - IgG2SA, Novus Biologicals™
Human Monoclonal Antibody
Manufacturer: Fischer Scientific
The price for this product is unavailable. Please request a quote
Antigen
Proprotein Convertase 9/PCSK9
Applications
Flow Cytometry, ELISA, Functional Assay
Conjugate
Unconjugated
Host Species
Human
Research Discipline
Cholesterol Metabolism, Lipid and Metabolism
Formulation
Lyophilized from 25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2)
Gene Alias
EC 3.4.21, EC 3.4.21.111, FH3neural apoptosis regulated convertase 1, HCHOLA3, hypercholesterolemia, autosomal dominant 3, LDLCQ1, NARC-1convertase subtilisin/kexin type 9 preproprotein, NARC1EC 3.4.21.-, Neural apoptosis-regulated convertase 1, PC9, Proprotein convertase 9, proprotein convertase subtilisin/kexin type 9, Subtilisin/kexin-like protease PC9
Immunogen
PCSK9
Primary or Secondary
Primary
Reconstitution
Reconstitute with sterile, distilled water to a final concentration of 1 mg/mL. Gently shake to solubilize completely. Do not vortex.
Clone
tafolecimab
Classification
Monoclonal
Form
Purified
Regulatory Status
RUO
Target Species
Human
Gene Accession No.
Q8NBP7
Gene ID (Entrez)
255738
Isotype
IgG2
Purification Method
Protein A purified
Content And Storage
Store at -20°C in powder form. Store at -80°C once reconstituted.
Related Products
Description
- Proprotein Convertase 9/PCSK9 Monoclonal antibody specifically detects Proprotein Convertase 9/PCSK9 in Human samples
- It is validated for Flow Cytometry,ELISA,Functional Assay
Compare Similar Items
Show Difference
Antigen: Proprotein Convertase 9/PCSK9
Applications: Flow Cytometry, ELISA, Functional Assay
Conjugate: Unconjugated
Host Species: Human
Research Discipline: Cholesterol Metabolism, Lipid and Metabolism
Formulation: Lyophilized from 25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2)
Gene Alias: EC 3.4.21, EC 3.4.21.111, FH3neural apoptosis regulated convertase 1, HCHOLA3, hypercholesterolemia, autosomal dominant 3, LDLCQ1, NARC-1convertase subtilisin/kexin type 9 preproprotein, NARC1EC 3.4.21.-, Neural apoptosis-regulated convertase 1, PC9, Proprotein convertase 9, proprotein convertase subtilisin/kexin type 9, Subtilisin/kexin-like protease PC9
Immunogen: PCSK9
Primary or Secondary: Primary
Reconstitution: Reconstitute with sterile, distilled water to a final concentration of 1 mg/mL. Gently shake to solubilize completely. Do not vortex.
Clone: tafolecimab
Classification: Monoclonal
Form: Purified
Regulatory Status: RUO
Target Species: Human
Gene Accession No.: Q8NBP7
Gene ID (Entrez): 255738
Isotype: IgG2
Purification Method: Protein A purified
Content And Storage: Store at -20°C in powder form. Store at -80°C once reconstituted.
Antigen:
Proprotein Convertase 9/PCSK9
Applications:
Flow Cytometry, ELISA, Functional Assay
Conjugate:
Unconjugated
Host Species:
Human
Research Discipline:
Cholesterol Metabolism, Lipid and Metabolism
Formulation:
Lyophilized from 25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2)
Gene Alias:
EC 3.4.21, EC 3.4.21.111, FH3neural apoptosis regulated convertase 1, HCHOLA3, hypercholesterolemia, autosomal dominant 3, LDLCQ1, NARC-1convertase subtilisin/kexin type 9 preproprotein, NARC1EC 3.4.21.-, Neural apoptosis-regulated convertase 1, PC9, Proprotein convertase 9, proprotein convertase subtilisin/kexin type 9, Subtilisin/kexin-like protease PC9
Immunogen:
PCSK9
Primary or Secondary:
Primary
Reconstitution:
Reconstitute with sterile, distilled water to a final concentration of 1 mg/mL. Gently shake to solubilize completely. Do not vortex.
Clone:
tafolecimab
Classification:
Monoclonal
Form:
Purified
Regulatory Status:
RUO
Target Species:
Human
Gene Accession No.:
Q8NBP7
Gene ID (Entrez):
255738
Isotype:
IgG2
Purification Method:
Protein A purified
Content And Storage:
Store at -20°C in powder form. Store at -80°C once reconstituted.
Antigen: TGF-beta RII
Applications: Flow Cytometry, ELISA, Functional Assay
Conjugate: Unconjugated
Host Species: Human
Research Discipline: Angiogenesis, Cell Biology, Cell Cycle and Replication
Formulation: Lyophilized from 25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2)
Gene Alias: AAT3, EC 2.7.11, EC 2.7.11.30, FAA3, HNPCC6, LDS1B, LDS2B, MFS2, RIIC, TAAD2, tbetaR-II, TGF-beta receptor type II, TGF-beta receptor type IIB, TGF-beta receptor type-2, TGF-beta type II receptor, TGFbeta-RII, TGFR-2, transforming growth factor beta receptor type IIC, transforming growth factor, beta receptor II (70/80kDa), transforming growth factor, beta receptor II (70/80kDa) isoform 1, transforming growth factor, beta receptor II (70/80kDa) isoform 2, transforming growth factor, beta receptor II (70-80kD), Transforming growth factor-beta receptor type II
Immunogen: TBFbR2
Primary or Secondary: Primary
Reconstitution: Reconstitute with sterile, distilled water to a final concentration of 1 mg/mL. Gently shake to solubilize completely. Do not vortex.
Clone: LY3022859
Classification: Monoclonal
Form: Purified
Regulatory Status: RUO
Target Species: Human
Gene Accession No.: P37173
Gene ID (Entrez): 7048
Isotype: IgG1
Purification Method: Protein A purified
Content And Storage: Store at -20°C in powder form. Store at -80°C once reconstituted.
Antigen:
TGF-beta RII
Applications:
Flow Cytometry, ELISA, Functional Assay
Conjugate:
Unconjugated
Host Species:
Human
Research Discipline:
Angiogenesis, Cell Biology, Cell Cycle and Replication
Formulation:
Lyophilized from 25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2)
Gene Alias:
AAT3, EC 2.7.11, EC 2.7.11.30, FAA3, HNPCC6, LDS1B, LDS2B, MFS2, RIIC, TAAD2, tbetaR-II, TGF-beta receptor type II, TGF-beta receptor type IIB, TGF-beta receptor type-2, TGF-beta type II receptor, TGFbeta-RII, TGFR-2, transforming growth factor beta receptor type IIC, transforming growth factor, beta receptor II (70/80kDa), transforming growth factor, beta receptor II (70/80kDa) isoform 1, transforming growth factor, beta receptor II (70/80kDa) isoform 2, transforming growth factor, beta receptor II (70-80kD), Transforming growth factor-beta receptor type II
Immunogen:
TBFbR2
Primary or Secondary:
Primary
Reconstitution:
Reconstitute with sterile, distilled water to a final concentration of 1 mg/mL. Gently shake to solubilize completely. Do not vortex.
Clone:
LY3022859
Classification:
Monoclonal
Form:
Purified
Regulatory Status:
RUO
Target Species:
Human
Gene Accession No.:
P37173
Gene ID (Entrez):
7048
Isotype:
IgG1
Purification Method:
Protein A purified
Content And Storage:
Store at -20°C in powder form. Store at -80°C once reconstituted.
Antigen: TGF-beta RII
Applications: Flow Cytometry, ELISA, Functional Assay
Conjugate: Unconjugated
Host Species: Human
Research Discipline: Angiogenesis, Cell Biology, Cell Cycle and Replication
Formulation: Lyophilized from 25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2)
Gene Alias: AAT3, EC 2.7.11, EC 2.7.11.30, FAA3, HNPCC6, LDS1B, LDS2B, MFS2, RIIC, TAAD2, tbetaR-II, TGF-beta receptor type II, TGF-beta receptor type IIB, TGF-beta receptor type-2, TGF-beta type II receptor, TGFbeta-RII, TGFR-2, transforming growth factor beta receptor type IIC, transforming growth factor, beta receptor II (70/80kDa), transforming growth factor, beta receptor II (70/80kDa) isoform 1, transforming growth factor, beta receptor II (70/80kDa) isoform 2, transforming growth factor, beta receptor II (70-80kD), Transforming growth factor-beta receptor type II
Immunogen: TBFbR2
Primary or Secondary: Primary
Reconstitution: Reconstitute with sterile, distilled water to a final concentration of 1 mg/mL. Gently shake to solubilize completely. Do not vortex.
Clone: LY3022859
Classification: Monoclonal
Form: Purified
Regulatory Status: RUO
Target Species: Human
Gene Accession No.: P37173
Gene ID (Entrez): 7048
Isotype: IgG1
Purification Method: Protein A purified
Content And Storage: Store at -20°C in powder form. Store at -80°C once reconstituted.
Antigen:
TGF-beta RII
Applications:
Flow Cytometry, ELISA, Functional Assay
Conjugate:
Unconjugated
Host Species:
Human
Research Discipline:
Angiogenesis, Cell Biology, Cell Cycle and Replication
Formulation:
Lyophilized from 25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2)
Gene Alias:
AAT3, EC 2.7.11, EC 2.7.11.30, FAA3, HNPCC6, LDS1B, LDS2B, MFS2, RIIC, TAAD2, tbetaR-II, TGF-beta receptor type II, TGF-beta receptor type IIB, TGF-beta receptor type-2, TGF-beta type II receptor, TGFbeta-RII, TGFR-2, transforming growth factor beta receptor type IIC, transforming growth factor, beta receptor II (70/80kDa), transforming growth factor, beta receptor II (70/80kDa) isoform 1, transforming growth factor, beta receptor II (70/80kDa) isoform 2, transforming growth factor, beta receptor II (70-80kD), Transforming growth factor-beta receptor type II
Immunogen:
TBFbR2
Primary or Secondary:
Primary
Reconstitution:
Reconstitute with sterile, distilled water to a final concentration of 1 mg/mL. Gently shake to solubilize completely. Do not vortex.
Clone:
LY3022859
Classification:
Monoclonal
Form:
Purified
Regulatory Status:
RUO
Target Species:
Human
Gene Accession No.:
P37173
Gene ID (Entrez):
7048
Isotype:
IgG1
Purification Method:
Protein A purified
Content And Storage:
Store at -20°C in powder form. Store at -80°C once reconstituted.
Antigen: OX40/TNFRSF4
Applications: Flow Cytometry, ELISA, Functional Assay
Conjugate: Unconjugated
Host Species: Human
Research Discipline: Adaptive Immunity, B Cell Development and Differentiation Markers, Cancer, Cell Cycle and Replication, Immunology, Myeloid derived Suppressor Cell, Signal Transduction
Formulation: Lyophilized from 25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2)
Gene Alias: ACT35 antigen, ACT35ATC35 antigen, CD134, CD134 antigen, OX40 cell surface antigen, OX40 homologue, OX40L receptor, OX40lymphoid activation antigene ACT35, TAX transcriptionally-activated glycoprotein 1 receptor, tax-transcriptionally activated glycoprotein 1 receptor, tumor necrosis factor receptor superfamily member 4, tumor necrosis factor receptor superfamily, member 4, TXGP1LOX40 antigen
Immunogen: TNFRSF4/ OX40/ CD134
Primary or Secondary: Primary
Reconstitution: Reconstitute with sterile, distilled water to a final concentration of 1 mg/mL. Gently shake to solubilize completely. Do not vortex.
Clone: telazorlimab
Classification: Monoclonal
Form: Purified
Regulatory Status: RUO
Target Species: Human
Gene Accession No.: P43489
Gene ID (Entrez): 7293
Isotype: IgG1
Purification Method: Protein A purified
Content And Storage: Store at -20°C in powder form. Store at -80°C once reconstituted.
Antigen:
OX40/TNFRSF4
Applications:
Flow Cytometry, ELISA, Functional Assay
Conjugate:
Unconjugated
Host Species:
Human
Research Discipline:
Adaptive Immunity, B Cell Development and Differentiation Markers, Cancer, Cell Cycle and Replication, Immunology, Myeloid derived Suppressor Cell, Signal Transduction
Formulation:
Lyophilized from 25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2)
Gene Alias:
ACT35 antigen, ACT35ATC35 antigen, CD134, CD134 antigen, OX40 cell surface antigen, OX40 homologue, OX40L receptor, OX40lymphoid activation antigene ACT35, TAX transcriptionally-activated glycoprotein 1 receptor, tax-transcriptionally activated glycoprotein 1 receptor, tumor necrosis factor receptor superfamily member 4, tumor necrosis factor receptor superfamily, member 4, TXGP1LOX40 antigen
Immunogen:
TNFRSF4/ OX40/ CD134
Primary or Secondary:
Primary
Reconstitution:
Reconstitute with sterile, distilled water to a final concentration of 1 mg/mL. Gently shake to solubilize completely. Do not vortex.
Clone:
telazorlimab
Classification:
Monoclonal
Form:
Purified
Regulatory Status:
RUO
Target Species:
Human
Gene Accession No.:
P43489
Gene ID (Entrez):
7293
Isotype:
IgG1
Purification Method:
Protein A purified
Content And Storage:
Store at -20°C in powder form. Store at -80°C once reconstituted.